Q-Med has obtained registration approval for Restylane® in China

Q-Med has obtained registration approval for Restylane® in China

Q-Med has obtained registration approval for Restylane® in China. An application
for sales approval will be submitted shortly and it is estimated that sales of
the product will begin at the end of the second quarter in 2009. 

“There is a large appetite for new things in China and great respect for
products from the West. We are therefore very pleased about this registration
approval, which means that Restylane® will be the first hyaluronic acid product
intended for the cosmetic market in China”, says Bengt Ågerup, Q-Med´s President
and CEO. 


Queries should be addressed to: 

Bengt Ågerup, President and CEO
Tel: +46 (0)70 974 9025
Madelene Sandgren, Director Investor Relations and Corporate Communications
Tel: +46 (0)70 974 9015 

Q-Med AB is a rapidly growing and profitable biotechnology/medical device
company. The company develops, manufactures, markets, and sells primarily
medical implants. The majority of the products are based on the company's
patented technology, NASHA™, for the production of stabilized non-animal
hyaluronic acid. The product portfolio today contains: Restylane® for filling
lines and folds, contouring and creating volume in the face, Macrolane™ for body
contouring, Durolane™ for the treatment of osteoarthritis of the hip and knee
joints, Deflux® for the treatment of vesicoureteral reflux, VUR, (a malformation
of the urinary bladder) in children, and Solesta™ for the treatment of fecal
incontinence. Sales are made through the company's own subsidiaries or
distributors in over 70 countries. Q Med today has just over 700 coworkers, with
close to 500 at the company's head office and production facility in Uppsala,
Sweden. Q-Med AB is listed in the Mid Cap segment of the OMX Nordic Exchange in
Stockholm.


Q-Med AB (publ), Seminariegatan 21, SE-752 28 Uppsala, Sweden. Corporate
identity number 556258-6882.
Tel: +46(0)18-474 90 00. Fax: +46(0)18-474 90 01. E-mail: info@q-med.com. Web:
www.q-med.com.

In USA, Q-Med AB's affiliate is the wholly-owned subsidiary Q-Med Scandinavia,
Inc.